|
BCKDK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62592161956354E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.19329024228909E-12 |
| Normal-vs-Stage2 |
3.22419999998491E-06 |
| Normal-vs-Stage3 |
8.93649598765478E-11 |
| Normal-vs-Stage4 |
6.03670002874424E-10 |
| Stage1-vs-Stage2 |
4.904200E-01 |
| Stage1-vs-Stage3 |
2.793800E-01 |
| Stage1-vs-Stage4 |
2.163700E-03 |
| Stage2-vs-Stage3 |
9.254800E-01 |
| Stage2-vs-Stage4 |
8.632300E-02 |
| Stage3-vs-Stage4 |
4.455600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
1.99617999999679E-05 |
| Normal-vs-Asian |
2.67499999928589E-09 |
| Caucasian-vs-AfricanAmerican |
2.562400E-01 |
| Caucasian-vs-Asian |
6.785200E-01 |
| AfricanAmerican-vs-Asian |
4.235000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98079996849287E-10 |
| Normal-vs-Female |
5.99520433297585E-15 |
| Male-vs-Female |
8.095400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.89389639923843E-11 |
| Normal-vs-Age(41-60Yrs) |
1.8730572648451E-12 |
| Normal-vs-Age(61-80Yrs) |
2.47910025841236E-10 |
| Normal-vs-Age(81-100Yrs) |
2.19559999999897E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.458400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.628160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.249200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.402600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.963800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.521400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.395600E-01 |
| Classical-VS-Follicular |
1.67610000001428E-06 |
| Classical-VS-Other |
7.202100E-02 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.232210E-04 |
| Tall-VS-Other |
2.178800E-01 |
| Tall-VS-Normal |
4.88189488834223E-11 |
| Follicular-VS-Other |
9.046800E-01 |
| Follicular-VS-Normal |
6.925600E-02 |
| Other-VS-Normal |
5.046200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.1494364328164E-12 |
| Normal-vs-N1 |
4.574000E-04 |
| N0-vs-N1 |
2.778200E-01 |
|
|
